Roundtable: Life Science Leader |
Article: Clinical Leader Head of Clinical Operations Erin O'Boyle: Ensuring Patient-Friendly Clinical Trials For Complex Disorders — A Small Biopharma's Playbook |
Article: International Biopharmaceutical Industry |
Interview: San Francisco Business Times CEO Nevan Elam with SF Busines Times' Ron Leuty: How an Israeli web service, a bong-like insulin device and a Bay Area deal led this Peninsula biotech to attack a childhood disease |
Interview: The Rare Daily CEO Nevan Elam with Global Genes' Marie Daghlian: Rezolute Gains Rare Pediatric Disease Designation for RZ358 in Congenital Hyperinsulinism |
Interview: Empowered Patient Podcast |
Nature's BioPharma Dealmakers |
Interview: Proactive Investors |